Primary Resistance to Alectinib Was Lost after Bevacizumab Combined Chemotherapy in ALK-Rearranged Lung Adenocarcinoma

Research output: Contribution to journalLetterpeer-review

3 Citations (Scopus)
Original languageEnglish
Pages (from-to)e168-e169
JournalJournal of Thoracic Oncology
Volume14
Issue number8
DOIs
Publication statusPublished - Aug 2019

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this